皓元医药
(688131)
| 流通市值：212.10亿 | | | 总市值：212.10亿 |
| 流通股本：2.13亿 | | | 总股本：2.13亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 1,647,974,323.92 | 728,650,826.78 | 2,876,896,205.58 | 2,059,065,717.06 |
| 营业总成本 | 1,384,319,166.19 | 617,062,250.99 | 2,442,468,503.31 | 1,692,413,729.4 |
| 其他经营收益 | | | | |
| 营业利润 | 193,528,202.55 | 74,188,573.15 | 296,753,268.18 | 289,384,618.05 |
| 利润总额 | 192,593,289.55 | 74,142,301.06 | 275,775,558.67 | 287,425,117.63 |
| 净利润 | 162,095,918.23 | 63,006,428.85 | 231,645,431.33 | 231,678,855.86 |
| 每股收益 | | | | |
| 其他综合收益 | -6,350,002.37 | -3,706,137.65 | -996,967.42 | -1,723,831.95 |
| 综合收益总额 | 155,745,915.86 | 59,300,291.2 | 230,648,463.91 | 229,955,023.91 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 4,178,700,097.12 | 4,008,893,053.7 | 3,787,891,366.55 | 3,715,026,308.81 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,520,348,784.91 | 2,480,645,614.24 | 2,506,382,734.4 | 2,355,409,813.77 |
| 资产总计 | 6,699,048,882.03 | 6,489,538,667.94 | 6,294,274,100.95 | 6,070,436,122.58 |
| 流动负债: | | | | |
| 流动负债合计 | 2,010,843,723.25 | 1,857,269,414.82 | 1,777,506,406.92 | 1,610,886,614.77 |
| 非流动负债: | | | | |
| 非流动负债合计 | 1,339,664,065.57 | 1,384,314,932.36 | 1,331,029,379.67 | 1,325,955,561.83 |
| 负债合计 | 3,350,507,788.82 | 3,241,584,347.18 | 3,108,535,786.59 | 2,936,842,176.6 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 3,314,097,632.43 | 3,209,240,514.99 | 3,136,045,549.31 | 3,112,196,065.04 |
| 股东权益合计 | 3,348,541,093.21 | 3,247,954,320.76 | 3,185,738,314.36 | 3,133,593,945.98 |
| 负债和股东权益合计 | 6,699,048,882.03 | 6,489,538,667.94 | 6,294,274,100.95 | 6,070,436,122.58 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,667,257,568.98 | 802,366,515.98 | 3,054,040,753.92 | 2,096,179,872.29 |
| 经营活动现金流出小计 | 1,590,192,967.52 | 765,795,218.42 | 2,736,291,724.3 | 2,001,600,478.35 |
| 经营活动产生的现金流量净额 | 77,064,601.46 | 36,571,297.56 | 317,749,029.62 | 94,579,393.94 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 2,359,760,410.41 | 1,546,637,248.88 | 4,537,927,477.47 | 3,302,942,359.66 |
| 投资活动现金流出小计 | 2,448,691,262.66 | 1,293,794,205.48 | 4,739,970,309.92 | 3,079,541,970.95 |
| 投资活动产生的现金流量净额 | -88,930,852.25 | 252,843,043.4 | -202,042,832.45 | 223,400,388.71 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 647,748,958.58 | 360,643,571.48 | 955,063,826.12 | 701,021,475.18 |
| 筹资活动现金流出小计 | 530,333,151.43 | 255,066,752.42 | 778,061,753.87 | 497,285,337.95 |
| 筹资活动产生的现金流量净额 | 117,415,807.15 | 105,576,819.06 | 177,002,072.25 | 203,736,137.23 |
| 汇率变动对现金及现金等价物的影响 | -49,104,530.46 | -17,323,622.87 | -1,083,949.13 | 8,282,087.85 |
| 现金及现金等价物净增加额 | 56,445,025.9 | 377,667,537.15 | 291,624,320.29 | 529,998,007.73 |
| 期末现金及现金等价物余额 | 1,221,165,018.92 | 1,542,387,530.17 | 1,164,719,993.02 | 1,403,093,680.46 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 56,445,025.9 | - | 291,624,320.29 | - |
最新报告期：2026-09-21| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 平安证券 | 叶寅,倪亦道,王钰畅 | 1.63 | 2.39 | 3.28 | 2026-09-21 |
| 西部证券 | 李梦园 | 1.64 | 2.21 | 3.14 | 2026-09-11 |
| 湘财证券 | 蒋栋 | 1.52 | 2.16 | 2.87 | 2026-09-01 |
| 兴业证券 | 乔波耀,孙媛媛,黄翰漾 | 1.65 | 2.35 | 3.32 | 2026-08-31 |
| 光大证券 | 曹聪聪 | 1.65 | 2.36 | 3.33 | 2026-08-31 |